Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology.
Jeroen Roosendaal
,
Hilde Rosing
,
Jos H Beijnen
More about this publication
Clinical pharmacology in drug development
Volume
9
Issue nr.
5
Pages
552-559
Publication date
01-07-2020
Full text links
Publisher website (DOI)
10.1002/cpdd.840
Europe PubMed Central
32573110
Pubmed
32573110